Nuvelo CEO Ted Love: An Interview With “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
A day after Nuvelo releases disappointing Phase III results for Bayer-partnered alfimeprase, Love discusses Nuvelo’s next steps for the thrombolytic, and other options in the company’s pipeline.